Business Case

Defining a go-to-market strategy that redefines a pharma company’s approach to the public sector in Mexico

A large pharmaceutical company anticipated faced trouble securing reimbursement for a novel therapy in Mexico and sought a go-to-market strategy that redefined their approach to the public sector in Mexico. In collaboration with our client, LSC crafted a comprehensive strategic framework to simultaneously analyze the market’s intricacies and refining the go-to-market approach based on the needs of stakeholders, considerations of payers and influence of other institutions. Through a series of strategic workshops encompassing diverse internal teams – from project management to scientific research – a cohesive strategy was shaped, pinpoint a value proposition for priority products, identifying the target audience, and outlining the necessary internal structure to support this renewed market approach.